Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: A 23-year follow-up study

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 6, 2014, Pages 474-480

  Li, Guangwei ^a,b   Zhang, Ping ^c   Wang, Jinping ^e   An, Yali ^b   Gong, Qiuhong ^b   Gregg, Edward W ^c   Yang, Wenying ^a   Zhang, Bo ^a   Shuai, Ying ^a   Hong, Jing ^a   Engelgau, Michael M ^d   Li, Hui ^e   Roglic, Gojka ^f   Hu, Yinghua ^e   Bennett, Peter H ^g  

^a CHINA JAPAN FRIENDSHIP HOSPITAL   (China)

^b FUWAI HOSPITAL   (China)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Da Qing First Hospital   (China)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

^g NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CHINA; DIABETES MELLITUS; DIETARY INTAKE; FEMALE; FOLLOW UP; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PREVENTION STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); BLOOD; CARDIOVASCULAR DISEASES; CLUSTER ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS, TYPE 2; EXERCISE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; INCIDENCE; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TIME; WEIGHT REDUCTION;

GLUCOSE BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHINA; CLUSTER ANALYSIS; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; FOLLOW-UP STUDIES; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK REDUCTION BEHAVIOR; TIME FACTORS; WEIGHT LOSS;

EID: 84901590227     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70057-9     Document Type: Article

References (33)

1. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997, 20:537-544.
2. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001, 344:1343-1350.
3. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393-403.
4. Ratner R, Goldberg R, Haffner S, et al. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005, 28:888-894.
5. Kosaka K, Noda M, Kuzuya T Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract 2005, 67:152-162.
6. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 2006, 49:289-297.
7. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008, 371:1783-1789.
8. Knowler WC, Fowler SE, Hamman RF, et al. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009, 374:1677-1686.
9. Saito T, Watanabe M, Nishida J, et al. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med 2011, 171:1352-1360.
10. Orchard TJ, Temprosa M, Barrett-Connor E, et al. Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med 2013, 30:46-55.
11. Lindstrom J, Peltonen M, Eriksson JG, et al. Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS). Diabetologia 2013, 56:284-293.
12. Uusitupa M, Peltonen M, Lindstrom J, et al. Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study-secondary analysis of the randomized trial. PLoS One 2009, 4:e5656.
13. Eriksson KF, Lindgarde F No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malmo Preventive Trial with diet and exercise. Diabetologia 1998, 41:1010-1016.
14. Gong Q, Gregg EW, Wang J, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study. Diabetologia 2011, 54:300-307.
15. Diabetes Mellitus. Report of a WHO Study Group. 727, 1-113 1985, WHO Study Group, World Health Organization, Geneva.
16. Collett D Modeling survival data in medical research 1994, Chapman & Hall, London.
17. Barnett KN, Ogston SA, McMurdo ME, Morris AD, Evans JM A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland. Diabet Med 2010, 27:1124-1129.
18. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011, 364:829-841.
19. Sievers ML, Nelson RG, Knowler WC, Bennett PH Impact of NIDDM on mortality and causes of death in Pima Indians. Diabetes Care 1992, 15:1541-1549.
20. Yamaoka K, Tango T Efficacy of lifestyle education to prevent type 2 diabetes: a meta-analysis of randomized controlled trials. Diabetes Care 2005, 28:2780-2786.
21. Hopper I, Billah B, Skiba M, Krum H Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 2011, 18:813-823.
22. Yoon U, Kwok LL, Magkidis A Efficacy of lifestyle interventions in reducing diabetes incidence in patients with impaired glucose tolerance: a systematic review of randomized controlled trials. Metabolism 2013, 62:303-314.
23. Wing RR, Reboussin D, Lewis CE Intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013, 369:2358-2359.
24. Knowler WC, Sartor G, Melander A, Schersten B Glucose tolerance and mortality, including a substudy of tolbutamide treatment. Diabetologia 1997, 40:680-686.
25. Kim NH, Pavkov ME, Looker HC, et al. Plasma glucose regulation and mortality in pima Indians. Diabetes Care 2008, 31:488-492.
26. Brun E, Nelson RG, Bennett PH, et al. Diabetes duration and cause-specific mortality in the Verona Diabetes Study. Diabetes Care 2000, 23:1119-1123.
27. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
28. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001, 161:1717-1723.
29. Gajalakshmi V, Peto R Commentary: verbal autopsy procedure for adult deaths. Int J Epidemiol 2006, 35:748-750.
30. Yang G, Rao C, Ma J, et al. Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol 2006, 35:741-748.
31. Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China. N Engl J Med 2010, 362:1090-1101.
32. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013, 310:948-959.
33. Diabetes Atlas 2011, International Diabetes Federation, International Diabetes Federation, Brussels. 5th edn.